Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Discover Hybrigenics Services new offer: ULTImate YChemH for your drug discovery & development projects

Product Image
Product Description

ULTImate YChemH (Yeast Chemical Hybrid) is an in-yeast compound profiling technique to identify protein partners of a given bioactive small molecule. Derived from Hybrigenics ULTImate Y2HTM (Yeast Two-Hybrid) service, it benefits from the same advantages with exhaustive screening of highly complex libraries, confidence score for partners ranking, minimal interaction domain determination and much more…


  • Identify hit targets and decipher mechanisms of action following a high-content screening
  • Study the off-target effect of an active compound
  • Support drug repositioning in new therapeutic areas
  • Evaluate safety of chemicals (toxico-proteomics) 



Key Benefits

  • Gain in productivity with additional resources
  • Benefit from our expertise in both chemistry and biology
  • Understand how your bioactive molecule works
  • Select the most promising molecule & develop it the optimal way

Contact our team of experts for any question or for a project discussion: 

+33 (0)1 58 10 38 29

Product Discover Hybrigenics Services new offer: ULTImate YChemH for your drug discovery & development projects
Company Hybrigenics Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Hybrigenics Services
3-5 Impasse Reille 75014 Paris France

Tel: +33 (0)1 58 10 38 29
Fax: +33 (0)1 58 10 38 48

Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos